U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C38H41N3O2
Molecular Weight 571.751
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIPICANA

SMILES

CCCCCN1C=C(C2C=CC=CC12)C(=O)N(C(=O)C3=CN(CCCCC)C4=CC=CC=C34)C5=CC=CC6=C5C=CC=C6

InChI

InChIKey=JUJSXRUYGOTLSI-UHFFFAOYSA-N
InChI=1S/C38H41N3O2/c1-3-5-13-24-39-26-32(30-19-9-11-21-34(30)39)37(42)41(36-23-15-17-28-16-7-8-18-29(28)36)38(43)33-27-40(25-14-6-4-2)35-22-12-10-20-31(33)35/h7-12,15-23,26-27,30,34H,3-6,13-14,24-25H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C38H41N3O2
Molecular Weight 571.751
Charge 0
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:47:57 GMT 2023
Edited
by admin
on Sat Dec 16 11:47:57 GMT 2023
Record UNII
PR85BBU47K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BIPICANA
Common Name English
N, N-BIS(1-PENTYLINDOL-3-YL-CARBOXY)NAPHTYLAMINE
Common Name English
N-(1-NAPHTHYL)-1-PENTYL-N-(1-PENTYL-3A,7A-DIHYDROINDOLE-3-CARBONYL)INDOLE-3-CARBOXAMIDE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-BiPICANA
Created by admin on Sat Dec 16 11:47:57 GMT 2023 , Edited by admin on Sat Dec 16 11:47:57 GMT 2023
Code System Code Type Description
FDA UNII
PR85BBU47K
Created by admin on Sat Dec 16 11:47:57 GMT 2023 , Edited by admin on Sat Dec 16 11:47:57 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
BIPICANA
Created by admin on Sat Dec 16 11:47:57 GMT 2023 , Edited by admin on Sat Dec 16 11:47:57 GMT 2023
PRIMARY (BiPICANA, compound 2). Compound 2 was purified by silica and octadecyl group bonded type silica gel (C18, ODS) columns and confirmed by liquid chromatographymass spectrometry, accurate mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray crystallography. No pharmacological information on compound 2 has been reported previouslyour experiments on the binding ability of compound 2 to cannabinoid receptors revealed that it has affinities for CB1 and CB2 receptors (EC50 = 3.80 and 8.77 107 M, respectively). This is the first report identifying compound 2 in a dubious herbal product and demonstrating its binding affinities to cannabinoid receptors.
PUBCHEM
162368425
Created by admin on Sat Dec 16 11:47:57 GMT 2023 , Edited by admin on Sat Dec 16 11:47:57 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY